MyHealthChecked (MHC) Competitors GBX 14.44 -0.31 (-2.07%) As of 12:16 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock MHC vs. NCYT, POLX, IHC, AVO, RUA, SUN, BELL, DEMG, NIOX, and SNShould you be buying MyHealthChecked stock or one of its competitors? The main competitors of MyHealthChecked include Novacyt (NCYT), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), Belluscura (BELL), Deltex Medical Group (DEMG), NIOX Group (NIOX), and Smith & Nephew (SN). These companies are all part of the "medical devices" industry. MyHealthChecked vs. Novacyt Polarean Imaging Inspiration Healthcare Group Advanced Oncotherapy RUA Life Sciences Surgical Innovations Group Belluscura Deltex Medical Group NIOX Group Smith & Nephew MyHealthChecked (LON:MHC) and Novacyt (LON:NCYT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, media sentiment, valuation, risk, community ranking and dividends. Does the MarketBeat Community believe in MHC or NCYT? Novacyt received 36 more outperform votes than MyHealthChecked when rated by MarketBeat users. CompanyUnderperformOutperformMyHealthCheckedN/AN/ANovacytOutperform Votes3658.06% Underperform Votes2641.94% Which has more volatility & risk, MHC or NCYT? MyHealthChecked has a beta of 1.37, meaning that its stock price is 37% more volatile than the S&P 500. Comparatively, Novacyt has a beta of -1.86, meaning that its stock price is 286% less volatile than the S&P 500. Is MHC or NCYT more profitable? MyHealthChecked has a net margin of -11.06% compared to Novacyt's net margin of -203.06%. MyHealthChecked's return on equity of -12.80% beat Novacyt's return on equity.Company Net Margins Return on Equity Return on Assets MyHealthChecked-11.06% -12.80% -8.18% Novacyt -203.06%-47.73%-27.98% Do insiders & institutionals hold more shares of MHC or NCYT? 3.1% of MyHealthChecked shares are held by institutional investors. Comparatively, 0.1% of Novacyt shares are held by institutional investors. 53.6% of MyHealthChecked shares are held by insiders. Comparatively, 3.1% of Novacyt shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer MHC or NCYT? In the previous week, MyHealthChecked's average media sentiment score of 0.00 equaled Novacyt'saverage media sentiment score. Company Overall Sentiment MyHealthChecked Neutral Novacyt Neutral Which has preferable earnings and valuation, MHC or NCYT? MyHealthChecked has higher earnings, but lower revenue than Novacyt. MyHealthChecked is trading at a lower price-to-earnings ratio than Novacyt, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMyHealthChecked£9.43M0.80-£1.04M-£2.00-7.20Novacyt£18.12M1.58-£36.80M-£54.44-0.76 SummaryMyHealthChecked beats Novacyt on 8 of the 12 factors compared between the two stocks. Remove Ads Get MyHealthChecked News Delivered to You Automatically Sign up to receive the latest news and ratings for MHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MHC vs. The Competition Export to ExcelMetricMyHealthCheckedMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£7.52M£3.54B£5.63B£2.60BDividend YieldN/A2.44%4.57%4.82%P/E Ratio-7.2079.2123.33141.21Price / Sales0.80130.74388.46281,678.09Price / Cash1.7815.9938.1627.94Price / Book0.993.806.894.61Net Income-£1.04M£126.02M£3.20B£5.78B7 Day Performance-4.02%-2.96%-3.02%1.37%1 Month Performance-23.97%-6.88%1.63%7.22%1 Year Performance17.92%-12.44%9.74%108.14% MyHealthChecked Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MHCMyHealthCheckedN/AGBX 14.45-2.1%N/A+23.8%£7.52M£9.43M-7.2016Gap UpNCYTNovacytN/AGBX 45-8.2%N/A-7.1%£31.09M£18.12M-0.83120Gap DownPOLXPolarean ImagingN/AGBX 1.20-2.0%N/A-74.4%£17.61M£5.21M-0.3128IHCInspiration Healthcare GroupN/AGBX 16.37-2.3%N/A-42.3%£14.18M£42.87M-1.12224Gap DownAVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 12.08-1.4%N/A+24.7%£7.49M£4.05M-2.8148SUNSurgical Innovations GroupN/AGBX 0.55+0.2%N/A+2.7%£5.14M£12.54M-21.1180News CoverageBELLBelluscuraN/AGBX 1.60-3.0%N/A-92.1%£4.03M£2.87M-0.1724Gap DownDEMGDeltex Medical GroupN/AGBX 0.01-71.4%N/AN/A£187,000.00£1.76M-0.1537Gap UpHigh Trading VolumeNIOXNIOX GroupN/AGBX 61.20-0.6%N/A+16.4%£25.14B£3.53B2,525.6292SNSmith & Nephew4.0879 of 5 starsGBX 1,105.50+1.1%GBX 4,607.50+316.8%+6.5%£12.12B£7.08B39.8018,452Insider TradeHigh Trading Volume Remove Ads Related Companies and Tools Related Companies Novacyt Competitors Polarean Imaging Competitors Inspiration Healthcare Group Competitors Advanced Oncotherapy Competitors RUA Life Sciences Competitors Surgical Innovations Group Competitors Belluscura Competitors Deltex Medical Group Competitors NIOX Group Competitors Smith & Nephew Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:MHC) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyHealthChecked PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share MyHealthChecked With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
